PipelineReview.com1d
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet’s Disease
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
SOLIGENIX, INC.: Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease
Study DUS-AUBD-01 opens patient enrollment PRINCETON, N.J., Nov. 14, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...
unilad3d
Doctor reveals six signs in your mouth that could mean you have a serious illness
Now this is a pretty serious one but any lumps, sores or spots in the mouth should see you speaking to your dentist pretty ...
Mena FN4d
H2ocean Launches Educational Webinar Series For Dental Professionals: Educating The Power Of Sea Salt In Oral Care
Understanding Aphthous Ulcers: From Triggers to Treatment ... This webinar will educate dental professionals on managing 'Chemo Mouth' – a set of symptoms including mucositis, dry mouth, infections, ...